From: microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Features | Cervical cancer, N (%) | Normal, N (%) |
---|---|---|
Total, n (%) | 66 (100.0) | 50 (100.0) |
Age | ||
  < 45 years | 20 (30.3) | 20 (40.0) |
  ≥ 45 years | 46 (69.7) | 30 (60.0) |
Histological type | ||
 ADC | 7 (10.6) |  |
 SCC | 59 (89.4) |  |
Tumor size | ||
  < 4 cm | 30 (45.5) |  |
  ≥ 4 cm | 36 (54.5) |  |
FIGO stage | ||
 IA-IIA | 29 (43.9) |  |
 IIB-IVB | 37 (56.1) |  |
Lymph node metastasis | ||
 No | 35 (53.0) |  |
 Yes | 31 (47.0) |  |
HPV E6/E7 expression | ||
 Negative | 12 (18.2) |  |
 Positive | 54 (81.8) |  |
Survival | ||
 Alive | 52 (78.8) |  |
 Died | 14 (21.2) |  |